四环医药(00460.HK)拟3月31日举行董事会会议批准年度业绩

Group 1 - The company, Four Seasons Pharmaceutical (00460.HK), announced that it will hold a board meeting on March 31, 2026, to approve the annual performance for the year ending December 31, 2025, and discuss the potential distribution of a final dividend [1]